Advaxis, Inc. ADXSD
We take great care to ensure that the data presented and summarized in this overview for Advaxis, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ADXSD
Top Purchases
Top Sells
About ADXSD
Insider Transactions at ADXSD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2024
|
Israel Biotech Fund I, L.P. Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
5,294,486
-10.46%
|
$5,294,486
$1.25 P/Share
|
|
Feb 07
2024
|
Israel Biotech Fund I, L.P. Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
27,847,159
+18.25%
|
$0
$0.4 P/Share
|
|
Oct 18
2023
|
Israel Biotech Fund I, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
1,317,716
+28.95%
|
-
|
|
Oct 18
2023
|
A Moon Growth Fund Limited Partnership > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
0
|
-
|
|
Jan 19
2023
|
David Sidransky Director |
BUY
Grant, award, or other acquisition
|
Indirect |
46
+50.0%
|
-
|
|
Oct 11
2017
|
Adage Capital Partners Gp, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
600,000
-12.77%
|
$2,400,000
$4.3 P/Share
|
|
Sep 26
2017
|
Adage Capital Partners Gp, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
300,000
-6.0%
|
$1,200,000
$4.0 P/Share
|
|
Sep 25
2017
|
Adage Capital Partners Gp, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
405,323
-7.5%
|
$1,621,292
$4.38 P/Share
|
|
Sep 22
2017
|
Adage Capital Partners Gp, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
534,000
-8.99%
|
$2,136,000
$4.68 P/Share
|
Last 12 Months Summary
Buy / Acquisition
29.2M
Shares
From
2
Insiders
| Exercise of conversion of derivative security | 27.8M shares |
|---|---|
| Open market or private purchase | 1.32M shares |
Sell / Disposition
5.29M
Shares
From
2
Insiders
| Other acquisition or disposition | 0 shares |
|---|---|
| Payment of exercise price or tax liability | 5.29M shares |